Development of a concept for a personalized approach in the perioperative antiplatelet therapy administration/discontinuation management based on multiple electrode aggregometry in patients undergoing coronary artery surgery

Journal of Thrombosis and Thrombolysis

Volumn 40, Issue 3, 2015, Pages 383-391

  Petricevic, Mate ^a   Milicic, Davor ^a   White, Alexandra ^a   Boban, Marko ^b   Mihaljevic, Martina Zrno ^a   Piljic, Dragan ^c   Rotim, Ante ^b   Buca, Ante ^d   Mihalj, Mario ^d   Biocina, Bojan ^a  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF RIJEKA   (Croatia)

^c UNIVERSITY CLINICAL CENTER TUZLA   (Bosnia and Herzegovina)

^d UNIVERSITY OF SPLIT   (Croatia)

Author keywords

Aspirin resistance; Coronary artery bypass surgery; Hemorrhage; Multiple electrode aggregometry; Platelet aggregation inhibitors; Platelet function

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PRASUGREL; TICAGRELOR;

AREA UNDER THE CURVE; ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; HUMAN; MULTIPLE ELECTRODE AGGREGOMETRY; PERSONALIZED MEDICINE; PLATELET REACTIVITY; POINT OF CARE TESTING; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; THROMBOCYTE FUNCTION; TREATMENT INDICATION; TREATMENT WITHDRAWAL; CORONARY BLOOD VESSEL; FEMALE; HEART SURGERY; MALE; PERIOPERATIVE PERIOD; PROCEDURES; SURGERY;

CARDIAC SURGICAL PROCEDURES; CORONARY VESSELS; FEMALE; HUMANS; MALE; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; PRECISION MEDICINE;

EID: 84940437552     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-015-1246-y     Document Type: Article

References (31)

1. Besser MW, Ortmann E, Klein AA (2015) Haemostatic management of cardiac surgical haemorrhage. Anaesthesia 70(Suppl 1):87-e31
2. Gasparovic H, Petricevic M, Biocina B (2014) Management of antiplatelet therapy resistance in cardiac surgery. J Thorac Cardiovasc Surg 147(3):855–862
3. Petricevic M, Kopjar T, Biocina B, Milicic D, Kolic K, Boban M et al (2015) The predictive value of platelet function point-of-care tests for postoperative blood loss and transfusion in routine cardiac surgery: a systematic review. Thorac Cardiovasc Surg 63(1):2–20
4. Petricevic M, Biocina B, Milicic D, Konosic S, Ivancan V, Milosevic M et al (2013) Bleeding risk assessment using multiple electrode aggregometry in patients following coronary artery bypass surgery. J Thromb Thrombolysis 35(1):31–40
5. Petricevic M, Biocina B, Milicic D, Konosic S, Svetina L, Lekic A et al (2013) Bleeding risk assessment using whole blood impedance aggregometry and rotational thromboelastometry in patients following cardiac surgery. J Thromb Thrombolysis 36(4):514–526
6. Petricevic M, Biocina B, Milicic D, Lekic A, Safradin I, Gasparovic H (2013) Multiple electrode aggregometry and prediction of bleeding and transfusion outcomes in adult cardiac surgery patients: methodological challenges and opportunities for future. Thorac Cardiovasc Surg 61(8):744–745
7. Gasparovic H, Petricevic M, Kopjar T, Djuric Z, Svetina L, Biocina B (2012) Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: study protocol for a randomized controlled trial [NCT01159639]. Trials 13:148
8. Gasparovic H, Petricevic M, Kopjar T, Djuric Z, Svetina L, Biocina B (2014) Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting. Am J Cardiol 113(10):1660–1667
9. Petricevic M, Biocina B, Konosic S, Burcar I, Siric F, Mihaljevic MZ et al (2013) Definition of acetylsalicylic acid resistance using whole blood impedance aggregometry in patients undergoing coronary artery surgery. Coll Antropol 37(3):833–839
10. Petricevic M, Biocina B, Konosic S, Kopjar T, Kunac N, Gasparovic H (2013) Assessment of platelet function by whole blood impedance aggregometry in coronary artery bypass grafting patients on acetylsalicylic acid treatment may prompt a switch to dual antiplatelet therapy. Heart Vessels 28(1):57–65
11. Petricevic M, Kopjar T, Gasparovic H, Milicic D, Svetina L, Zdilar B et al (2014) Impact of aspirin resistance on outcomes among patients following coronary artery bypass grafting: exploratory analysis from randomized controlled trial (NCT01159639). J Thromb Thrombolysis. doi:10.1007/s11239-014-1127-9
12. Petricevic M, Biocina B, Mihaljevic MZ, Boban M, Samardzic J, Konosic S et al (2014) Preoperative prasugrel discontinuation management in coronary artery surgery. Thorac Cardiovasc Surg. doi:10.1055/s-0034-1390156
13. Petricevic M, Biocina B, Safradin I, Gasparovic H (2013) Preoperative aspirin discontinuation management and bleeding outcome in elective coronary artery surgery. Thorac Cardiovasc Surg 61(8):731–732
14. Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U et al (2008) Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 34(1):73–92
15. Mehta RH, Roe MT, Mulgund J, Ohman EM, Cannon CP, Gibler WB et al (2006) Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 48(2):281–286
16. Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG et al (2011) ACCF/AHA guideline for coronary artery bypass graft surgery. a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol 58(24):e123–e210
17. Ferraris VA, Saha SP, Oestreich JH, Song HK, Rosengart T, Reece TB et al (2012) 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg 94(5):1761–1781
18. Furuno T, Yamasaki F, Yokoyama T, Sato T, Doi Y, Sugiura T (2011) Effects of various doses of aspirin on platelet activity and endothelial function. Heart Vessels 26:267–273
19. Awidi A, Saleh A, Dweik M, Kailani B, Abu-Fara M, Nabulsi R, Bener A (2011) Measurement of platelet reactivity of patients with cardiovascular disease on-treatment with acetyl-salicylic acid: a prospective study. Heart Vessels 26(5):516–522
20. Wang X, Gong X, Zhu T, Zhang Q, Zhang Y, Wang X, Yang Z, Li C (2014) Clopidogrel improves aspirin response after off-pump coronary artery bypass surgery. J Biomed Res 28(2):108–113
21. Youn YN, Yi G, Lee S, Joo HC, Yoo KJ (2014) Posttreatment platelet reactivity on clopidogrel is associated with the risk of adverse events after off-pump coronary artery bypass. Am Heart J 167(6):818–825
22. Samardzic J, Krpan M, Skoric B, Pasalic M, Petricevic M, Milicic D (2014) Serial clopidogrel dose adjustment after platelet function testing improves outcome of acute coronary syndrome patients undergoing percutaneous coronary intervention with high on-treatment platelet reactivity. J Thromb Thrombolysis 38(4):459–469
23. Sibbing D, Schulz S, Braun S, Morath T, Stegherr J, Mehilli J et al (2010) Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. J Thromb Haemost 8(2):250–256
24. Di Dedda U, Ranucci M, Baryshnikova E, Castelvecchio V, Surgical and Clinical Outcome Group (2014) Thienopyridines resistance and recovery of platelet function after discontinuation of thienopyridines in cardiac surgery patients. Eur J Cardiothorac Surg 45(1):165–170
25. Ranucci M, Colella D, Baryshnikova E, Di Dedda U, Surgical and Clinical Outcome Research (SCORE) Group (2014) Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery. Br J Anaesth 113(6):970–976. doi:10.1093/bja/aeu315
26. Karon BS, Tolan NV, Koch CD, Wockenfus AM, Miller RS, Lingineni RK, Pruthi RK, Chen D, Jaffe AS (2014) Precision and reliability of 5 platelet function tests in healthy volunteers and donors on daily antiplatelet agent therapy. Clin Chem 60(12):1524–1531. doi:10.1373/clinchem.2014.226332
27. Aradi D, Storey RF, Komócsi A, Trenk D, Gulba D, Kiss RG, Husted S, Bonello L, Sibbing D, Collet JP, Huber K (2014) Working Group on Thrombosis of the European Society of Cardiology. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention. Eur Heart J 35(4):209–215. doi:10.1093/eurheartj/eht375
28. Patrono C, Andreotti F, Arnesen H, Badimon L, Baigent C, Collet JP, De Caterina R, Gulba D, Huber K, Husted S, Kristensen SD, Morais J, Neumann FJ, Rasmussen LH, Siegbahn A, Steg PG, Storey RF, Van de Werf F, Verheugt F (2011) Antiplatelet agents for the treatment and prevention of atherothrombosis. Eur Heart J 32(23):2922–2932. doi:10.1093/eurheartj/ehr373
29. Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG (2007) A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 28(14):1702–1708
30. ® analyser. Platelets 24(4):303–307. doi:10.3109/09537104.2012.694086
31. Sambu N, Warner T, Curzen N (2011) Clopidogrel withdrawal: is there a “rebound” phenomenon? Thromb Haemost 105(2):211–220